One Stop Shop for All Your Market Research Reports

Human Rabies Vaccine Market, Global Outlook and Forecast 2023-2029

Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus. There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite. This report aims to provide a comprehensive presentation of the global market for Human Rabies Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rabies Vaccine. This report contains market size and forecasts of Human Rabies Vaccine in global, including the following market information: Global Human Rabies Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions) Global Human Rabies Vaccine Market Sales, 2018-2023, 2024-2029, (K Units) Global top five Human Rabies Vaccine companies in 2022 (%) The global Human Rabies Vaccine market was valued at US$ 1086.6 million in 2022 and is projected to reach US$ 1441 million by 2029, at a CAGR of 4.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share. Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%. The classification of Human Rabies Vaccine includes Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, and Others. In addition, the proportion of Vero Cell rabies vaccines is about 85%. Human Rabies Vaccine is widely used for Pre-exposure and Post-exposure. The segment of Human Rabies Vaccine used for Post-exposure and the market share is over 70% of the share. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Rabies Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Human Rabies Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units) Global Human Rabies Vaccine Market Segment Percentages, by Type, 2022 (%) Vero Cell BHK Chick Embryo Cell Human Diploid Cells Others Global Human Rabies Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units) Global Human Rabies Vaccine Market Segment Percentages, by Application, 2022 (%) Pre-Exposure Vaccine Post-Exposure Vaccine Global Human Rabies Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units) Global Human Rabies Vaccine Market Segment Percentages, By Region and Country, 2022 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Human Rabies Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions) Key companies Human Rabies Vaccine revenues share in global market, 2022 (%) Key companies Human Rabies Vaccine sales in global market, 2018-2023 (Estimated), (K Units) Key companies Human Rabies Vaccine sales share in global market, 2022 (%) Further, the report presents profiles of competitors in the market, key players include: Bharat Biotech Bavarian Nordic Sanofi-Pasteur Chengda Bio KANGH Prcmise Henan Grand Biopharma Zhuoyi Biological ZhongKe Biopharm Ningbo Rongan Biological Indian Immunologicals Outline of Major Chapters: Chapter 1: Introduces the definition of Human Rabies Vaccine, market overview. Chapter 2: Global Human Rabies Vaccine market size in revenue and volume. Chapter 3: Detailed analysis of Human Rabies Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Human Rabies Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Global Human Rabies Vaccine capacity by region & country. Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports 1.1 Human Rabies Vaccine Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Human Rabies Vaccine Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3250
Multi User US $4225
Corporate User US $4875
About this Report
Report ID 930731
Category
  • Pharmaceuticals and Healthcare
Published on 24-Jan
Number of Pages 79
Publisher Name Market Monitor Global
Editor Rating
★★★★★
★★★★★
(8)